ANALYSIS OF NON-PHARMACOLOGICAL COST SAVINGS DERIVED FROM THE USE OF FIXED- DOSE COMBINATION OF PERTUZUMAB AND TRASTUZUMAB FOR SUBCUTANEOUS INJECTION IN PATIENTS WITH HER2POSITIVE BREAST CANCER IN SPAIN

被引：0

作者：

Calleja, T. ^{[1
]}

Galve-Calvo, E. ^{[2
]}

Gomez Agudo, E. ^{[3
]}

Llaguno, J. L. ^{[4
]}

Martin Rufo, M. ^{[5
]}

Arroyo, I ^{[6
]}

Lagunar Ruiz, J. ^{[6
]}

Lores, M. ^{[7
]}

Monzon, M. ^{[8
]}

Saura, C. ^{[9
]}

机构：

[1] Farmaceut Adjunta Serv La Coruna SERGAS, La Coruna, Spain

[2] Hosp Univ Basurto OSI Bilbao Basurto, Bilbao, Spain

[3] Hosp San Pedro De Alcantara, Caceres, Spain

[4] Hosp Ramon Y Cajal FIBio HRC, Madrid, Spain

[5] Hosp Ramon & Cajal, Madrid, Spain

[6] Roche Farma SA, Madrid, Spain

[7] Hygeia Consulting SL, Madrid, Spain

[8] Hygeia Consulting SL, Salamanca, SA, Spain

[9] Hosp Univ Vall dHebron, Vall dHebron Inst Oncol VHIO, Barcelona, Spain

来源：

关键词：

D O I：

暂无

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

EE528

引用

页码：S153 / S153

页数：1